ACT Capital Management’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$853K Hold
2022
Q2
$696K Sell
2022
Q1
$1.59M Hold
2021
Q4
$1.58M Buy
2021
Q3
$1.92M Buy
2021
Q2
$2.45M Buy